Lead- and drug-like compounds: the rule-of-five revolution.
By Christopher A. Lipinski. Drug Discovery Today : Technologies, 2004
5,544 citations recorded by the source corpus.
Subfields: Computational Theory and Mathematics, Oncology, Organic Chemistry
View Paper: https://www.semanticscholar.org/paper/40412d274386872bf4a6f235505692864d864946
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Computational Theory and Mathematics
- B. Springthorpe
- Olivier Elemento
- Kaitlyn M. Gayvert
- Paul D. Leeson
- H. Pajouhesh
- Neel S. Madhukar
- G. R. Lenz
- Michael J. Waring
In Oncology
- B. Springthorpe
- Olivier Elemento
- Kaitlyn M. Gayvert
- Paul D. Leeson
- H. Pajouhesh
- Neel S. Madhukar
- G. R. Lenz
In Organic Chemistry
- B. Springthorpe
- Olivier Elemento
- Y. Ogawa
- Osamu Kobayashi
- K. Hirai
- Etsuko Tokunaga
- Kaitlyn M. Gayvert
- Paul D. Leeson
Citations in the corpus
- Medicinal chemical properties of successful central nervous system drugs (2005, background): “As such, medicinal chemists have enthusiastically adopted the Rule of Five.(81) Two studies have contrasted physical chemical properties of CNS-marketed drugs to either non-CNS drugs in general or to other classes of non-CNS drugs.”
- The influence of drug-like concepts on decision-making in medicinal chemistry (2007, background): “jpg" NDATA ITEM> ]> Ten years have passed since the publication of the 'rule of five' physical property guidelines for drug permeabilit”
- A data-driven approach to predicting successes and failures of clinical trials (2016, result): “…we reasoned that a new approach that includes overlooked features related to the results of a drug’s performance could prove to be highly impactful, similar to the effect that adopting sabermetrics had on the base-ball scouting process as described in Michael Lewis’s Moneyball (Lewis, 2003).”